Inclusion Criteria:

- Study participants who the investigator or delegate believes that they and/or their
parents/legally acceptable representative can and will comply with the requirements
of the protocol should be enrolled in the study.

- A male or female between, and including, 12 and 15 years of age at the time of the
first vaccination.

- A written informed assent must be obtained from all study participants prior to
enrolment. In addition, a written informed consent must be obtained from the study
participants' parent or legally acceptable representative.

- Healthy male and female study participants as established by medical history before
entering into the study.

- Study participants must not be pregnant. Absence of pregnancy should be verified as
per investigator's or delegate's clinical judgement.

- If the study participant is female, she must be of non-childbearing potential, or if
she is of childbearing potential, she must use adequate contraception for 30 days
prior to vaccination and continue for 2 months after completion of the vaccination
series.

Exclusion Criteria:

- Previous vaccination against HPV or Hepatitis B virus.

- History of allergic disease or reactions likely to be exacerbated by any component of
the vaccines.

- Acute disease at the time of enrolment.

- Pregnant or lactating female.